The US FTC requires global suppliers of animal health products to divest assets in 3 product markets as a condition for merger clearance (Elanco / Bayer)

Federal Trade Commission, US

Previous article The EFTA Surveillance Authority renews decision requiring disclosure of net short positions of 0.1% and above during the COVID-19 pandemic Next article The UK Competition Authority publishes guidance on its approach to merger control during the COVID-19 pandemic

15 Jul 2020

The US FTC requires global suppliers of animal health products to divest assets in 3 product markets as a condition for merger clearance (Elanco / Bayer)

KEYWORDS

References

US FTC, Elanco / Bayer, Press release, 15 July 2020

US FTC, Elanco / Bayer, Complaint, 15 July 2020

FTC Requires Global Suppliers of Animal Health Products Elanco Animal Health, Inc. and Bayer Animal Health GmbH to Divest Assets in Three Product Markets, as a Condition of Merger* The Federal Trade Commission will require global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elanco’s proposed $7.6 billion acquisition of Bayer would

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

US Federal Trade Commission
US Federal Trade Commission (FTC) (Washington)

United States 149 contributions 36480 visits

Quotation

US Federal Trade Commission, The US FTC requires global suppliers of animal health products to divest assets in 3 product markets as a condition for merger clearance (Elanco / Bayer), 15 July 2020, e-Competitions Interim measures, Art. N° 95860

Visites 215